Studying of various aspects of interaction doctor-parents-patient is one of the most actual problems in paediatrics. To assess patient compliance a variety of methods are used. The most effective, non-invasive and fastest for practical medicine is the questionnaire method. The aim of our work was to find correlations between different aspects of compliance to treatment concerning parents of children with CF and to evaluate overall compliance both at general and individual levels. Methods: 58 parents whose children suffer from CF were surveyed. The survey was conducted by interviewing, with using of developed questionnaire which includes 31 questions. Statistical analysis carried out in the environment for statistical computing R 3.0.1. Results: We assume the values of the compliance score <70% as a low level of compliance, the values from 70% to 90% − medium level and above 90% − high level. 24% of respondents were having low level of compliance, 50% medium, and 26% high.
Objectives: Adherence to medications in cystic fibrosis (CF) is poor. Studies demonstrated adherence rates of 40−50%. Poor adherence has been associated with lower lung function studies (PFTs) and greater frequency of pulmonary exacerbations. Methods: A retrospective review of prescription refill data over 5 years was conducted for several CF medications. Adherence was defined as having refilled at least 75% of the prescribed medications. PFTs, body mass indices (BMI) and hospitalization rates over the study period were collected. Results: Refill data were obtained for 177 patients, divided into 3 groups: (1) 0−5 years, (2) 6−12 years, (3) 13−21 years. Groups 1 and 2 had higher PFTs at baseline (p = 0.0003) and over the course of the study (p < 0.0001). Group 1 had an increase in PFTs over time, Group 2 had a decline (p = 0.003). Adherence was highest in Group 1 (p = 0.011). Adherence to hypertonic saline (IHS) was significantly higher in Groups 1 and 2 compared to Group 3 (p = 0.028). Adhering to IHS resulted in a significant improvement in PFTs in Group 2 (p = 0.025). Adhering to pancreatic enzymes (PE) resulted in a significant improvement in BMI percentile after controlling for age, gender and time (p = 0.029). There was a trend towards improved adherence to Pulmozyme in Group 1 compared to other groups. There was a decrease in adherence to vitamins over time in all age groups (p = 0.007). Adherence to TOBI showed lower PFTs (p = 0.002) and BMI percentiles (p = 0.019). Conclusion: Age was a strong predictor of adherence, with group 1 having better adherence. IHS and PE resulted in improved BMI. IHS improved PFT. TOBI use was associated with lower PFTs and BMI, likely due to patients being sicker. 8%] according to national standard criteria and selfreported adherence noted from a previous study (CFQ-R self-report). Coefficients of variation for FEV 1 , weight and CRP, were calculated from all contact points over the previous year and days iv therapy were noted. All measures were compared across disease severity bandings (ANOVA one-way).
Results: Differences across Bands were demonstrated for all parameters. Self-report adherence did not show a consistent trend, although iv antibiotic treatment, CoV weight and FEV 1 increase with severity. Band 4 had the lowest self-report adherence and highest variation in CRP. Conclusion: Self-report adherence consistently exceeds medication collection. Coefficient variation of FEV 1 may be an indirect measure of adherence.
